6-bromopurine

Identification

Generic Name
6-bromopurine
DrugBank Accession Number
DB02168
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 199.008
Monoisotopic: 197.954108763
Chemical Formula
C5H3BrN4
Synonyms
  • 6-bromo-1H-purine
External IDs
  • BB-127E

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UNucleoside deoxyribosyltransferase-INot AvailableLactobacillus helveticus
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as purines and purine derivatives. These are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Imidazopyrimidines
Sub Class
Purines and purine derivatives
Direct Parent
Purines and purine derivatives
Alternative Parents
Halopyrimidines / Aryl bromides / Imidazoles / Heteroaromatic compounds / Azacyclic compounds / Organonitrogen compounds / Organobromides / Hydrocarbon derivatives
Substituents
Aromatic heteropolycyclic compound / Aryl bromide / Aryl halide / Azacycle / Azole / Halopyrimidine / Heteroaromatic compound / Hydrocarbon derivative / Imidazole / Organic nitrogen compound
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
767-69-1
InChI Key
CTGFGRDVWBZYNB-UHFFFAOYSA-N
InChI
InChI=1S/C5H3BrN4/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H,7,8,9,10)
IUPAC Name
6-bromo-7H-purine
SMILES
BrC1=NC=NC2=C1NC=N2

References

General References
Not Available
PubChem Compound
5287830
PubChem Substance
46506278
ChemSpider
4450126
ZINC
ZINC000005783717
PDBe Ligand
BP1
PDB Entries
1s2i

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)>300 °CPhysProp
Predicted Properties
PropertyValueSource
Water Solubility8.73 mg/mLALOGPS
logP0.6ALOGPS
logP0.64Chemaxon
logS-1.4ALOGPS
pKa (Strongest Acidic)8.5Chemaxon
pKa (Strongest Basic)2.11Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area54.46 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity41.67 m3·mol-1Chemaxon
Polarizability14.2 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9973
Blood Brain Barrier+0.9651
Caco-2 permeable-0.6043
P-glycoprotein substrateNon-substrate0.7269
P-glycoprotein inhibitor INon-inhibitor0.9391
P-glycoprotein inhibitor IINon-inhibitor0.9302
Renal organic cation transporterNon-inhibitor0.7752
CYP450 2C9 substrateNon-substrate0.8971
CYP450 2D6 substrateNon-substrate0.8821
CYP450 3A4 substrateNon-substrate0.7576
CYP450 1A2 substrateInhibitor0.7975
CYP450 2C9 inhibitorNon-inhibitor0.5321
CYP450 2D6 inhibitorNon-inhibitor0.9797
CYP450 2C19 inhibitorNon-inhibitor0.8244
CYP450 3A4 inhibitorNon-inhibitor0.7354
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7531
Ames testAMES toxic0.6334
CarcinogenicityNon-carcinogens0.9596
BiodegradationNot ready biodegradable0.9879
Rat acute toxicity2.7945 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.961
hERG inhibition (predictor II)Non-inhibitor0.9352
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0002-2900000000-25a49366f6eb094d9f83
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-295fe162e7593b298999
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-37d045f92f5063b3499a
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-a4495ce6af2a029a0111
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-37d045f92f5063b3499a
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052b-0900000000-fe8c1eaa3cf1f98e4a96
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-37d045f92f5063b3499a
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-117.123024
predicted
DeepCCS 1.0 (2019)
[M+H]+120.20735
predicted
DeepCCS 1.0 (2019)
[M+Na]+129.12572
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Lactobacillus helveticus
Pharmacological action
Unknown
General Function
Nucleoside deoxyribosyltransferase activity
Specific Function
Not Available
Gene Name
ptd
Uniprot ID
Q8RLY5
Uniprot Name
Nucleoside 2-deoxyribosyltransferase
Molecular Weight
18713.08 Da

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52